<DOC>
	<DOCNO>NCT02707913</DOCNO>
	<brief_summary>The purpose study compare bioavailability generic product amlodipine reference product administer healthy volunteer fast condition . The test product name BF-Amlodipine Tablet 10mg manufacture Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited , reference product Norvasc Tablet 10mg . The plasma pharmacokinetic data amlodipine obtain two formulation use access interchangeability product</brief_summary>
	<brief_title>Clinical Bioequivalence Study Two Amlodipine Tablet 10mg Formulations</brief_title>
	<detailed_description>The study design single-dose , two-treatment , two-period , two-sequence crossover washout period two three week . During session , subject administer single oral dose 10mg amlodipine ( one BF-Amlodipine Tablet 10mg one Norvasc Tablet 10mg ) overnight fast approximately 10 hour . Venous blood sample collect pre-dose ( 0 h ) , 96 h post dose . The plasma concentration amlodipine determine validated assay . The non-compartmental method use analyze plasma concentration-time data calculate main pharmacokinetic parameter Peak plasma concentration ( Cmax ) , Time maximum concentration ( Tmax ) , Area plasma concentration versus time curve ( AUC0-last , AUC0-inf ) Elimination half-life ( T1/2 ) . Analysis Variance ( ANOVA ) conduct logarithmically transform Cmax , AUC0-last AUC0-inf . The two one side test use calculate 90 % confidence interval mean difference AUC0-last , AUC0-inf Cmax , assess bioequivalence two product</detailed_description>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Body Mass Index 18 27 Accessible vein blood sample High probability compliance completion study No significant abnormality general physical examination Electrocardiogram ( ECG ) record within normal limit Biochemical haematological parameter within normal limit Subjects must agree take effective contraceptive method prevent pregnancy start screen two week last dose administration History hepatic , renal , biliary , cardiovascular , gastrointestinal , haematological chronic acute disease within 3 month prior study Clinically relevant abnormality physical examination , ECG evaluation , urine test , blood chemistry haematological test Tobacco use form Regular consumer alcohol Blood donation within 4 week prior start study Use amlodipine within 4 week study Use antihypertensive medication within 4 week study Volunteer clinical drug study within 2 month prior study Hypersensitivity amlodipine drug class History drug abuse form Female subject breastfeed pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>